PR NEWSWIRE

Previous Stories

Security Matters Limited Streamlines Compliance with UK’s Plastic Packaging Tax

Feb 09 2022 - PR NewsWire

Digital innovations pave the way for industrial ease MELBOURNE, Australia, Feb. 9, 2022 /PRNewswire/ — Australia-based Security Matters (SMX), a…


Atlantic Nickel delivers record operational and financial performance in 2021

Feb 09 2022 - PR NewsWire

LONDON, Feb. 9, 2022 /PRNewswire/ — Atlantic Nickel ("Atlantic Nickel" or the "Company") and Appian Capital Advisory LLP ("Appian") are…


Bugworks Research Inc. secures US$18M Series B1 Funding from Reputed Global Investor Syndicate (The EU, UK, Japan, South Africa & India), led by Lightrock I

Feb 09 2022 - PR NewsWire

This Funding will advance highly differentiated assets in the dual areas of Antimicrobial Resistance (AMR) and Immuno-Oncology (IO) BANGALORE, India,…


Infosys Digital Radar 2022 Finds Technology Adoption Alone No Longer the Key to Unlocking Success and Profits

Feb 08 2022 - PR NewsWire

Report finds companies can gain $357 billion in annual profits globally through people-focused transformation efforts and a commitment to ESG…


Sedgwick University expands world-class training to Australia

Feb 08 2022 - PR NewsWire

SYDNEY, Feb. 8, 2022 /PRNewswire/ – Sedgwick, a leading global provider of technology-enabled risk, benefits and integrated business solutions, will begin…


IonOpticks enters OEM partnership with Bruker that sets a new standard for mass spectrometry-based research

Feb 08 2022 - PR NewsWire

IonOpticks on track to become the global leader of chromatography for proteomics applications MELBOURNE, Australia, Feb. 8, 2022 /PRNewswire/ —…


US FDA Study May Proceed letter for Clarity’s Cu-64 SAR-bisPSMA trial in prostate cancer

Feb 08 2022 - PR NewsWire

SYDNEY, Feb. 7, 2022 /PRNewswire/ — Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the…


KAZIA THERAPEUTICS TO PRESENT AT BIO CEO CONFERENCE

Feb 08 2022 - PR NewsWire

SYDNEY, Feb. 7, 2022 /PRNewswire/ — Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased…


Former NAB and ‘big four’ executive joins fintech CrowdProperty Australia to spearhead investment growth

Feb 07 2022 - PR NewsWire

SYDNEY, Feb. 7, 2022 /PRNewswire/ — Diana Shoolman, former head of professional services at NAB, and former director at PwC…


1bill announces strategic investment in Accurassi

Feb 07 2022 - PR NewsWire

Multi-million-dollar investment to transform Australia’s energy landscape and unlock the future of global energy retail MELBOURNE, Australia, Feb. 7, 2022…


Analyse The Market From A Different Angle